# Alex R. Chang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alex-r-chang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 79,417 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 62 |
| i10-index | 167 |
| Last Known Institution | Geisinger Health System |
| OpenAlex ID | https://openalex.org/A5031574122 |
| ORCID iD | https://orcid.org/0000-0002-8114-7447 |
| Works | 442 |

## Researcher papers

Showing 12 of 15.

- [Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2020-update-a-report-from-the-american-heart/)
- [Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2019-update-a-report-from-the-american-heart/)
- [Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2018-update-a-report-from-the-american-heart/)
- [Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017](https://scholariq.org/papers/global-regional-and-national-burden-of-chronic-kidney-disease-1990-2017-a/)
- [Development and Validation of the American Heart Association’s PREVENT Equations](https://scholariq.org/papers/development-and-validation-of-the-american-heart-association-s-prevent-equations/)
- [Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease](https://scholariq.org/papers/proton-pump-inhibitor-use-and-the-risk-of-chronic-kidney-disease/)
- [Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial](https://scholariq.org/papers/efficacy-and-safety-of-oral-semaglutide-in-patients-with-type-2-diabetes-and/)
- [Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes](https://scholariq.org/papers/estimated-glomerular-filtration-rate-albuminuria-and-adverse-outcomes/)
- [Conversion of Urine Protein–Creatinine Ratio or Urine Dipstick Protein to Urine Albumin–Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis](https://scholariq.org/papers/conversion-of-urine-protein-creatinine-ratio-or-urine-dipstick-protein-to-urine/)
- [Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis](https://scholariq.org/papers/serum-potassium-and-adverse-outcomes-across-the-range-of-kidney-function-a-ckd/)
- [Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies](https://scholariq.org/papers/change-in-albuminuria-and-subsequent-risk-of-end-stage-kidney-disease-an/)
- [A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury](https://scholariq.org/papers/a-meta-analysis-of-the-association-of-estimated-gfr-albuminuria-diabetes/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)

## Researcher university

- [Geisinger Health System](https://scholariq.org/institutions/geisinger-health-system/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.